share_log

海吉亞醫療:翌日披露報表

HYGEIA HEALTH: Next Day Disclosure Return

HKEX ·  Sep 13 18:12
Summary by Futu AI
海吉亞醫療控股有限公司(海吉亞醫療)於2024年9月13日提交了新的翌日披露報表,披露公司股份變動情況。報表顯示,海吉亞醫療在2024年9月2日至9月13日期間,通過香港聯合交易所有限公司(香港聯交所)的規定進行了股份購回,並擬註銷相關股份。購回的股份總數為4,757,400股,佔已發行股份的0.7533%。購回價格範圍在HKD 15.04至HKD 18.2396之間。公司確認,所有購回活動均已獲得董事會授權,並符合相關法律及規定。此外,公司在購回股份後將進入一個月的暫止期,直至2024年10月13日,期間不得發行新股或出售任何庫存股份。
海吉亞醫療控股有限公司(海吉亞醫療)於2024年9月13日提交了新的翌日披露報表,披露公司股份變動情況。報表顯示,海吉亞醫療在2024年9月2日至9月13日期間,通過香港聯合交易所有限公司(香港聯交所)的規定進行了股份購回,並擬註銷相關股份。購回的股份總數為4,757,400股,佔已發行股份的0.7533%。購回價格範圍在HKD 15.04至HKD 18.2396之間。公司確認,所有購回活動均已獲得董事會授權,並符合相關法律及規定。此外,公司在購回股份後將進入一個月的暫止期,直至2024年10月13日,期間不得發行新股或出售任何庫存股份。
Hygeia Health Holdings Limited (Hygeia Health) submitted a new next-day disclosure report on September 13, 2024, disclosing changes in the company's shares. The report shows that Hygeia Health repurchased shares in accordance with the regulations of The Stock Exchange of Hong Kong Limited (Hong Kong Stock Exchange) from September 2 to September 13, 2024, and intends to cancel the relevant shares. The total number of repurchased shares is 4,757,400 shares, accounting for 0.7533% of the issued shares. The repurchase price ranges from HKD 15.04 to HKD 18.2396. The company confirms that all repurchase activities have been authorized by the board of directors and comply with relevant laws and regulations. In addition, the company will enter a one-month moratorium period after the repurchase of shares, until October 13, 2024, during which no new shares may be issued or any inventory shares may be sold.
Hygeia Health Holdings Limited (Hygeia Health) submitted a new next-day disclosure report on September 13, 2024, disclosing changes in the company's shares. The report shows that Hygeia Health repurchased shares in accordance with the regulations of The Stock Exchange of Hong Kong Limited (Hong Kong Stock Exchange) from September 2 to September 13, 2024, and intends to cancel the relevant shares. The total number of repurchased shares is 4,757,400 shares, accounting for 0.7533% of the issued shares. The repurchase price ranges from HKD 15.04 to HKD 18.2396. The company confirms that all repurchase activities have been authorized by the board of directors and comply with relevant laws and regulations. In addition, the company will enter a one-month moratorium period after the repurchase of shares, until October 13, 2024, during which no new shares may be issued or any inventory shares may be sold.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.